← Back to Screener
GENPACT LIMITED (G)
Price$36.63
Favorite Metrics
Price vs S&P 500 (26W)-14.86%
Price vs S&P 500 (4W)-9.85%
Market Capitalization$6.25B
P/E Ratio (Annual)11.30x
Indicated Dividend Yield (Annual)2.07%
All Metrics
P/CF (Annual)7.68x
Book Value / Share (Quarterly)$14.97
P/TBV (Annual)3.25x
Indicated Dividend (Annual)$0.68
Revenue Growth (3Y)5.14%
Cash Flow / Share (Quarterly)$4.25
Payout Ratio (TTM)21.31%
Price vs S&P 500 (YTD)-25.17%
Gross Margin (TTM)36.04%
Net Profit Margin (TTM)10.88%
EPS (TTM)$3.13
10-Day Avg Trading Volume2.58M
EPS Excl Extra (TTM)$3.13
Revenue Growth (5Y)6.49%
EPS (Annual)$3.13
Dividend / Share (Annual)$0.68
ROI (Annual)13.44%
Gross Margin (Annual)36.04%
Net Profit Margin (5Y Avg)10.60%
Cash / Share (Quarterly)$7.08
P/E Basic Excl Extra (TTM)11.30x
Revenue Growth QoQ (YoY)5.65%
EPS Growth (5Y)14.71%
P/E Normalized (Annual)11.30x
ROA (Last FY)9.46%
Revenue Growth TTM (YoY)6.56%
EBITD / Share (TTM)$4.51
ROE (5Y Avg)22.01%
Operating Margin (TTM)14.77%
Cash Flow / Share (Annual)$4.25
P/B Ratio2.45x
P/B Ratio (Quarterly)3.16x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.41x
Net Interest Coverage (TTM)18.30x
ROA (TTM)10.32%
EPS Growth QoQ (YoY)3.24%
EV / EBITDA (TTM)8.99x
EPS Incl Extra (Annual)$3.13
Current Ratio (Annual)1.66x
Quick Ratio (Quarterly)1.59x
3-Month Avg Trading Volume2.11M
52-Week Price Return-24.52%
EV / Free Cash Flow (Annual)9.88x
P/E Incl Extra (TTM)11.30x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$14.57
P/S Ratio (Annual)1.23x
Asset Turnover (Annual)0.87x
52-Week High$50.41
Operating Margin (5Y Avg)13.55%
EPS Excl Extra (Annual)$3.13
CapEx CAGR (5Y)1.94%
Tangible BV CAGR (5Y)9.22%
26-Week Price Return-10.87%
Quick Ratio (Annual)1.59x
13-Week Price Return-23.11%
Total Debt / Equity (Annual)0.61x
Current Ratio (Quarterly)1.66x
Enterprise Value$7,158.933
Revenue / Share Growth (5Y)8.71%
Asset Turnover (TTM)0.95x
Book Value / Share Growth (5Y)9.05%
Revenue / Employee (Annual)$0
Pretax Margin (Annual)14.37%
Cash / Share (Annual)$7.08
3-Month Return Std Dev40.94%
Gross Margin (5Y Avg)35.46%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)10.42%
EBITDA Interim CAGR (5Y)10.16%
ROE (Last FY)21.67%
Net Interest Coverage (Annual)18.30x
EPS Basic Excl Extra (Annual)$3.13
P/FCF (TTM)8.62x
Receivables Turnover (TTM)4.05x
EV / Free Cash Flow (TTM)9.88x
Total Debt / Equity (Quarterly)0.61x
EPS Incl Extra (TTM)$3.13
Receivables Turnover (Annual)4.05x
ROI (TTM)14.29%
Dividend Growth Rate (5Y)11.76%
P/S Ratio (TTM)1.23x
Pretax Margin (5Y Avg)12.93%
Revenue / Share (Annual)$28.76
Tangible BV / Share (Annual)$14.57
Forward P/E9.12x
Free OCF CAGR (5Y)7.53%
Price vs S&P 500 (52W)-54.35%
P/E Ratio (TTM)11.30x
EPS Growth TTM (YoY)9.85%
Year-to-Date Return-22.53%
5-Day Price Return1.97%
EPS Normalized (Annual)$3.13
ROA (5Y Avg)9.60%
Net Profit Margin (Annual)10.88%
Month-to-Date Return-2.71%
Cash Flow / Share (TTM)$2.81
EBITD / Share (Annual)$4.51
EPS Growth (3Y)18.52%
Operating Margin (Annual)14.77%
LT Debt / Equity (Annual)0.46x
P/CF (TTM)7.68x
ROI (5Y Avg)13.31%
P/E Excl Extra (TTM)11.30x
LT Debt / Equity (Quarterly)0.46x
EPS Basic Excl Extra (TTM)$3.13
P/TBV (Quarterly)3.25x
Payout Ratio (Annual)21.31%
P/B Ratio (Annual)3.16x
Dividend / Share (TTM)$0.68
Pretax Margin (TTM)14.37%
Book Value / Share (Annual)$14.97
Price vs S&P 500 (13W)-23.79%
Net Margin Growth (5Y)5.54%
Dividend Yield (TTM)1.89%
Beta0.69x
P/FCF (Annual)8.62x
Revenue / Share (TTM)$29.03
ROE (TTM)21.81%
52-Week Low$33.92
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.80
3.80
3.80
3.80
Industry Peers — Management Consulting(23)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|
GGENPACT LIMITED | 11.30x | 21.81% | 6.49% | 2.07% | $36.63 |
GIBCGI Inc. | 12.98x | 16.37% | 5.52% | 0.63% | $75.27 |
BAHBooz Allen Hamilton Holding Corporation | 10.61x | 82.04% | 9.93% | 2.87% | $82.69 |
FCNFTI Consulting, Inc. | 20.57x | 14.38% | 9.01% | — | $182.25 |
EXPOExponent Inc | 31.67x | 25.51% | 7.79% | 1.82% | $68.12 |
HURNHuron Consulting Group Inc. | 20.97x | 21.03% | 14.30% | — | $131.47 |
ASTHAstrana Health Inc. Common Stock | 65.20x | 2.93% | 35.87% | — | $30.60 |
ICFIICF International, Inc. | 14.71x | 9.11% | 4.44% | 0.77% | $72.91 |
MEGMontrose Environmental Group, Inc. | — | -0.17% | 20.40% | — | $20.88 |
BWMNBowman Consulting Group Ltd. Common Stock | 42.37x | 5.06% | 32.06% | — | $30.90 |
RMRThe RMR Group Inc. Class A Common Stock | 30.30x | 10.11% | 3.50% | 10.88% | $16.58 |
About
Genpact is a digital transformation company providing technology-enabled services across data operations, AI solutions, and business process optimization. It serves high-tech, manufacturing, financial services, and healthcare sectors, generating the majority of revenue from India. Core offerings include decision support services, application lifecycle management, data engineering, generative AI, and agentic technology consulting.